Ariella Coler-Reilly Selected Research

poly(ethyleneglycol-lactide)

3/2013

Pathogenesis of Hand-Foot Syndrome induced by PEG-modified liposomal Doxorubicin.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Ariella Coler-Reilly Research Topics

Disease

3	Tropical Spastic Paraparesis (Tropical Spastic Paraplegia) 12/2022 - 01/2013
2	COVID-19 01/2020 - 01/2020
2	Inflammation (Inflammations) 08/2014 - 09/2013
1	Cryptococcosis 02/2020
1	Invasive Fungal Infections 02/2020
1	Genetic Predisposition to Disease (Genetic Predisposition) 01/2020
1	Thrombophilia 01/2020
1	Rheumatoid Arthritis 02/2017
1	Infections 01/2015
1	Spinal Cord Diseases 01/2015
1	Cardiotoxicity 03/2013
1	Alopecia (Baldness) 03/2013
1	Ovarian Neoplasms (Ovarian Cancer) 03/2013
1	Hand-Foot Syndrome 03/2013
1	Disease Progression 01/2013

Drug/Important Bio-Agent (IBA)

2	NeopterinIBA 01/2020 - 01/2013
2	Biomarkers (Surrogate Marker)IBA 01/2020 - 01/2013
1	Adrenal Cortex Hormones (Corticosteroids)IBA 12/2022
1	Hydroxychloroquine (Plaquenil)FDA LinkGeneric 01/2020
1	SteroidsIBA 01/2020
1	Complement Inactivating AgentsIBA 01/2020
1	Complement System Proteins (Complement)IBA 01/2020
1	Antirheumatic Agents (DMARD)IBA 02/2017
1	mogamulizumabIBA 01/2015
1	Viral ProteinsIBA 08/2014
1	Transcription Factors (Transcription Factor)IBA 08/2014
1	ChemokinesIBA 09/2013
1	liposomal doxorubicin (Doxil)FDA Link 03/2013
1	poly(ethyleneglycol-lactide)IBA 03/2013
1	Chemokine CXCL10IBA 01/2013

Therapy/Procedure

2	Therapeutics 12/2022 - 02/2020
1	Off-Label Use 01/2020